High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.

被引：3
|
作者：
Tureci, Ozlem
Itoh, Kyogo
Yamaguchi, Rin
Mukhina, Svetlana
Sahin, Ugur
Rohde, Christoph
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15584
引用
收藏
页数：5
相关论文
共 50 条
  • [41] High prevalence of CagA-positive Helicobacter pylori in Japanese patients irrelevant to the presence of peptic ulcers and gastric cancer.
    Maeda, S
    Ogura, K
    Kanai, F
    Ikenoue, T
    Yoshida, H
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1997, 112 (04) : A205 - A205
  • [42] A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer.
    Bai, Chunmei
    Xue, Junli
    Zheng, Yi
    Sun, Meili
    Ying, Jieer
    Zhou, Fuxiang
    Yu, Yiyi
    Sun, Yuping
    Xing, Ligang
    Zhang, Yanqiao
    Wen, Jinhua
    Xiong, Jianping
    Wu, Heshui
    Yang, Xiuli
    Wan, Lixin
    Guo, Shiwei
    Zhao, Rusen
    Zhu, Zhizhen
    Gong, Zhihua
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Clinicopathologic Characterization of Claudin 18.2 Expression in Surgically-Resected Gastric and Esophageal Adenocarcinomas
    Wong, Amanda
    Pai, Reetesh
    Davison, Jon
    Ma, Changqing
    LABORATORY INVESTIGATION, 2024, 104 (03) : S849 - S851
  • [44] Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?
    Mathias-Machado, Maria Cecilia
    de Jesus, Victor Hugo Fonseca
    Jacome, Alexandre
    Donadio, Mauro Daniel
    Aruquipa, Marcelo Porfirio Sunagua
    Fogacci, Joao
    Cunha, Renato Guerino
    da Silva, Leonard Medeiros
    Peixoto, Renata D'Alpino
    CANCERS, 2024, 16 (03)
  • [45] A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer.
    Xu, Rui-Hua
    Ruan, Dan-Yun
    Zhang, Dong-Sheng
    Liu, Fu-Rong
    Luo, Su-Xia
    Zhuang, Zhi-Xiang
    Wang, Zhen-Ning
    Liu, Fu-Nan
    Zhang, Yan-Qiao
    Yang, Jian-Wei
    Chen, Zhen-Dong
    Wang, Yong-Sheng
    Wang, Jun-Ye
    Liang, Xiao-Hua
    Wu, Xiao-Jie
    Zheng, Yu-Long
    Liu, Jian
    Shi, Xi
    Liu, Wei
    Chen, Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36_SUPPL) : 434420 - 434420
  • [46] Relationship between [18F]FDG PET/CT findings and claudin 18.2 expression in metastatic gastric cancer
    Yin, Hongyan
    Luo, Rongkui
    Lv, Jing
    Mao, Wujian
    Shi, Hongcheng
    EUROPEAN RADIOLOGY, 2024,
  • [47] Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
    Prabhsimranjot Singh
    Sudhamshi Toom
    Yiwu Huang
    Journal of Hematology & Oncology, 10
  • [48] A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer.
    Xu, Rui-Hua
    Ruan, Dan-Yun
    Zhang, Dong-Sheng
    Liu, Fu-Rong
    Luo, Su-Xia
    Zhuang, Zhi-Xiang
    Wang, Zhen-Ning
    Liu, Fu-Nan
    Zhang, Yan-Qiao
    Yang, Jian-Wei
    Chen, Zhen-Dong
    Wang, Yong-Sheng
    Wang, Jun-Ye
    Liang, Xiao-Hua
    Wu, Xiao-Jie
    Zheng, Yu-Long
    Liu, Jian
    Shi, Xi
    Liu, Wei
    Chen, Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [49] Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
    Singh, Prabhsimranjot
    Toom, Sudhamshi
    Huang, Yiwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [50] Claudin18.2 bispecific T-cell engager for gastric cancer immunotherapy
    Pandian, Swarna
    Li, Zusheng
    Chan, Eugene
    Markelewicz, Robert
    Wyant, Timothy
    Lakshmikanthan, Sribalaji
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345